AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsSign up free
🇿🇦

Oxybutynin Chloride in South Africa

8 products registered with SAHPRA — 5 active

Brand / ProductReg. No.HolderStatusExpires
OXYSPAS35/5.4/0111Cipla Medpro (Pty) Ltdsuspended17 Jul 2025
LYRINEL 10 mgA39/5.4/0224Janssen Pharmaceutica (Pty) Ltdsuspended7 Oct 2022
LYRINEL 5 mgA39/5.4/0212Janssen Pharmaceutica (Pty) Ltdsuspended7 Oct 2022
LENDITRO33/5.4/0411Pharmacare Limited û Woodmeadactive1 Jan 1900
CIPLA-OXYBUTYNIN CHLORIDE35/5.4/0340CIPLA LIFE SCIENCES (PTY) LTDactive1 Jan 1900
OXYREST37/5.4/0106iPharma (Pty) Ltdactive1 Jan 1900
MYLAN OXYBUTYNIN 532/5.4/0740Viatris South Africa (Pty) Ltdactive1 Jan 1900
DITROPANL/5.4/104Pharmaco Distribution (Pty) Ltdactive1 Jan 1900

Oxybutynin Chloride — SAHPRA Registration Details

SAHPRA (South Africa) has 8 registered products containing Oxybutynin Chloride, of which 5 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.

Track Oxybutynin Chloride registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.